Imprivata helps organizations enable fast, secure, DEA-compliant EPCS to fight drug diversion, improve prescribing workflows, increase patient safety, and comply with increasing state-level EPCS mandates

In healthcare, it sometimes seems there’s only one constant: change. This ever-shifting landscape makes it extremely difficult for healthcare organizations to meet the goals of managing identity and access to care – particularly amidst increasing pressure to simultaneously improve patient care and reduce costs.

Imprivata establishes trust across the people, devices, applications, data, and clinical workflows that contribute to the delivery of patient care

Lexington, Mass.–March 1, 2018—Imprivata®, the healthcare IT security company, will showcase innovative technologies that enable care providers to address critical compliance and security challenges while improving overall productivity and the patient experience at the HIMSS18 Annual Conference & Exhibition (March 5-9 in Las Vegas).

On the eve of the HIMSS18 Conference & Exhibition (March 5-9 in Las Vegas), the U.S. Senate provided the biggest boost yet to the already surging momentum behind electronic prescribing for controlled substances (EPCS).